Medicine and Dentistry
Glaucoma
100%
Mitomycin
76%
Venous Thromboembolism
76%
Deep Vein Thrombosis
59%
Bleeding
48%
Low Molecular Weight Heparin
46%
Trabeculectomy
46%
Intraocular Pressure
42%
Eye Injury
38%
Prognostic Factor
38%
Cataract Surgery
38%
Descemet Membrane Endothelial Keratoplasty
38%
Vitamin K Antagonist
38%
Clinical Finding
38%
Choroidal Neovascularization
38%
Lens Capsule Rupture
38%
Age Related Macular Degeneration
38%
Bullous Keratopathy
38%
Telemedicine in Ophthalmology
38%
Spectral Domain Optical Coherence Tomography
38%
Occult Cancer
38%
Glaucoma Valve
38%
Retina Macula Cystoid Edema
38%
Implant
38%
Optic Nerve
38%
Melanoma
38%
Effusion
38%
Combination Therapy
38%
Radical Surgery
38%
Upper Extremity Deep Vein Thrombosis
38%
Oncolytic Virus
38%
Uterine Cervix
38%
Pulmonary Embolism
33%
Bruch's Membrane
30%
Retinal Nerve Fiber Layer
30%
Recurrent Disease
29%
Severe Acute Respiratory Syndrome
23%
Intravitreal Administration
19%
Bevacizumab
19%
Progression Free Survival
19%
Rare Disease
19%
Recurrence Risk
19%
Best Corrected Visual Acuity
17%
Odds Ratio
17%
Major Bleeding
17%
Refractive Error
15%
COVID-19
15%
Cell Density
15%
Peroperative Complication
15%
Endothelial Cell
15%
Nursing and Health Professions
Venous Thromboembolism
76%
Bleeding
65%
Upper Extremity Deep Vein Thrombosis
38%
Confidence Interval
38%
Subretinal Neovascularization
38%
Age Related Macular Degeneration
38%
Low Molecular Weight Heparin
38%
Antivitamin K
38%
Recurrent Disease
29%
Lung Embolism
25%
Deep Vein Thrombosis
21%
Bevacizumab
19%
Intravitreal Drug Administration
19%
Odds Ratio
17%
Vein Thrombosis
12%
Visual Acuity
9%
Exudate
9%
Best Corrected Visual Acuity
9%
Early Intervention
9%
Laser Coagulation
9%
Edema
9%
Early Diagnosis
9%
Anticoagulant Therapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
76%
Deep Vein Thrombosis
59%
Bleeding
51%
Low Molecular Weight Heparin
46%
Antivitamin K
38%
Glaucoma
38%
Upper Extremity Deep Vein Thrombosis
38%
Lung Embolism
33%
Recurrent Disease
29%
Severe Acute Respiratory Syndrome
23%
Vein Thrombosis
12%
Anticoagulant Agent
8%
Direct Oral Anticoagulant
7%
All Cause Mortality
7%
Open Angle Glaucoma
7%
Pandemic
7%
